Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study

Circulation

Volumn 99, Issue 23, 1999, Pages 3028-3035

  Lévy, Samuel ^a   Maarek, Martine ^b   Coumel, Philippe ^b   Guize, Louis ^b   Lekieffre, Jean ^b   Medvedowsky, Jean Louis ^b   Sebaoun, Alain ^b  

^a HÔPITAL NORD   (France)

^b NONE

Author keywords

Antiarrhythmia agents; Atrial; Embolism; Fibrillation

Indexed keywords

ACETYLDIGITOXIN; ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIGITOXIN; DIGOXIN; HEPARIN; SOTALOL; WARFARIN;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; FRANCE; GENERAL PRACTICE; HEART ATRIUM FIBRILLATION; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SEX DIFFERENCE; THROMBOEMBOLISM;

EID: 2542507510     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.23.3028     Document Type: Article

References (25)

1. Cabin HS, Clubb KS, Hall C, Perlmutter RA, Feinstein AR. Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol. 1990;61:714-717.
2. Wolf PA, Abbott RD, Kannel WB. A major contributor to stroke in the elderly. Arch Int Med. 1987;147:1561-1564.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988.
4. Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke. 1986;17:622-626.
5. Bialy D, Lehmann MH, Schumacher DN, Steinman RT, Meissmer MD. Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. J Am Coll Cardiol. 1992;19(supp13):41A. Abstract.
6. Takahashi N. Clinical features of proxysmal atrial fibrillation. An observation of 94 patients. Stroke. 1986;17:622-626.
7. Kerr C, Boone J, Connolly S, Greene M, Klein G, Sheldon R, Talajic M. Follow-up of atrial fibrillation: the initial experience of the Canadian Registry of Atrial Fibrillation. Eur Heart J. 1996;17(suppl C):48-51.
8. Radford MD, Evans DW. Long-term results of DC reversion of atrial fibrillation. Br Heart J. 1968;30:91-96.
9. Resnekov L, McDonald L. Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion. Br Heart J. 1967;29:926-936.
10. Hurst JW, Paulk EA, Proctor HD, Schlant RC. Management of patients with atrial fibrillation. Am J Med. 1964;37:728-741.
11. Boissel JP, Wolf E, Gilet J, Soubrane A, Cavallaro A, Mazoyer G, Delahaye JP. Controlled trial of a long acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation. Eur Heart J. 1981;2:49-55.
12. Godtfresen J. Atrial fibrillation: course and prognosis. A follow-up study of 1212 cases. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial Fibrillation. Mölndal, Sweden: AB Hässle; 1982;134-145.
13. Kulbertus HE, Leval-Rutten F, Bartsh P, Petit JM. Atrial fibrillation in elderly ambulatory patients. In: Kulbertus HE, Olsson SB, Schlepper M, eds. Atrial Fibrillation. Mölndal, Sweden: AB Hässle; 1982:148-154.
14. Delahaye JP, Milon H, Boissonat P. La fibrillation auriculaire: quelques problèmes pratiques actuels. Ann Cardiol Angeiol. 1986;35:597-606.
15. Davidson E, Weinbeger I, Rotenberg Z, Fusch SJ, Agmon J. Causes and time of onset of atrial fibrillation. Arch Intern Med. 1989;149:457-459.
16. Bellet S. Atrial fibrillation (clinical manifestations) In: Clinical Disorders of the Heartbeat. Philadelphia, Pa: Lea and Febiger; 1971:223-233.
17. Devereux RB, Reichek N. Echocardiographic determination of the left ventricular mass. Anatomic variation of the method. Circulation. 1977; 55:613-618.
18. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwanz PJ, Simon P, for the European Myocardial Infarct Amiodarone Trial Investigators. Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after a recent myocardial infarction. Lancet. 1997;349:667-674.
19. Royston JP. An extension of Shapiro and Wilk's test for normality to large samples. Appl Statistics. 1982;31:115-124.
20. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Statistics Assoc. 1952;47:583-621.
21. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 1987;317: 669-674.
22. Brand FN, Abott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA. 1985;254:3449-3453.
23. Evans W, Swann P. Lone auricular fibrillation. Br Heart J. 1954;16: 189-194.
24. Kannel WB, Abbot RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983; 106:389-396.
25. Page RL, Wilkinson WE, Clair WK, McArthy EA, Pritchett EC. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994; 89:224-227.